首页> British Journal of Clinical Pharmacology> Lack of effect of tofacitinib (CP-690,550) on the pharmacokinetics of the CYP3A4 substrate midazolam in healthy volunteers: Confirmation of in vitro data

Lack of effect of tofacitinib (CP-690,550) on the pharmacokinetics of the CYP3A4 substrate midazolam in healthy volunteers: Confirmation of in vitro data

导出原文传递

翻译打印收藏纠错

第一作者： Gupta,P.

作者： Gupta,P. ^[1] ; Alvey,C. ^[2] ; Wang,R. ; Dowty,M.E. ; Fahmi,O.A. ; Walsky,R.L. ; Riese,R.J. ; Krishnaswami,S.

作者单位： Pfizer Inc., Groton, CT, United States ^[1] Pfizer Inc., Andover, MA, United States ^[2]

关键词 CYP3A Drug-drug interaction Janus kinase inhibitor Pharmacokinetics and drug metabolism Rheumatology/immunology

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

British Journal of Clinical Pharmacology

2012年74卷1期

109-115页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

British Journal of Clinical Pharmacology

2012年74卷1期

109-115页

检索历史清除

Lack of effect of tofacitinib (CP-690,550) on the pharmacokinetics of the CYP3A4 substrate midazolam in healthy volunteers: Confirmation of in vitro data

British Journal of Clinical Pharmacology

相似文献

同项目论文

British Journal of Clinical Pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Lack of effect of tofacitinib (CP-690,550) on the pharmacokinetics of the CYP3A4 substrate midazolam in healthy volunteers: Confirmation of in vitro data

British Journal of Clinical Pharmacology

相似文献

同项目论文

British Journal of Clinical Pharmacology

相关期刊

检索历史清除